SCHEMBL4894370

SCHEMBL4894370

CC(C)(C)[Si](C)(C)OCCCOc1ccccc1[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.60
RAB9A P51151 4/20 0.60
RECQL P46063 2/20 0.60
ALDH1A1 P00352 7/20 0.53
HTT P42858 4/20 0.53
KMT2A Q03164 3/20 0.52
LMNA P02545 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
MAPT P10636 3/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
HPGD P15428 1/20 0.50
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 1/20 0.49
MAPK1 P28482 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.47
TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13086536 0.93 NPC1 (0.67) NPC1RAB9ARECQLALDH1A1HTT
SCHEMBL30467895 0.93 NPC1 (0.67) NPC1RAB9ARECQLALDH1A1HTT
SCHEMBL22499475 0.87 NPC1 (0.44) NPC1RAB9ARECQLALDH1A1HTT
SCHEMBL9642715 0.82 NPC1 (0.89) NPC1RAB9ARECQLALDH1A1HTT
SCHEMBL358808 0.82 S1PR4 (0.53) NPC1RAB9AALDH1A1KMT2ALMNA
SCHEMBL621432 0.82 NPC1 (0.42) NPC1RAB9ARECQLALDH1A1HTT
SCHEMBL3368986 0.82 NPC1 (0.50) NPC1RAB9ARECQLALDH1A1HTT
SCHEMBL618812 0.81 NPC1 (0.41) NPC1RAB9ARECQLALDH1A1HTT
SCHEMBL10246030 0.81 ALDH1A1 (0.64) NPC1RAB9ARECQLALDH1A1HTT
SCHEMBL12635368 0.81 NPC1 (0.49) NPC1RAB9ARECQLALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080305169-A1 Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds JAPAN TOBACCO INC. (JP) 2008-12-11 US disclosed
US-20080064871-A1 Production Method of Nitrogen-Containing Fused Ring Compounds JAPAN TOBACCO INC. (JP) 2008-03-13 US disclosed
EP-1820515-A1 NITROGEN-CONTAINING FUSED RING COMPOUND AND USE THEREOF Japan Tobacco, Inc. (JP) 2007-08-22 EP disclosed
US-20070010670-A1 Nitrogen-containing fused ring compounds and use thereof JAPAN TOBACCO INC. (JP) 2007-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080305169-A1 Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds NOD1, NLRP3, SLC10A1 NPC1 145/4885RAB9A 3804/4885RECQL 1521/4885
US-20070010670-A1 Nitrogen-containing fused ring compounds and use thereof NUDT1, NOD1, SLC28A1 NPC1 489/4885RAB9A 3487/4885RECQL 2249/4885
US-20080064871-A1 Production Method of Nitrogen-Containing Fused Ring Compounds NOD1, XDH, URB2 NPC1 924/4885RAB9A 3325/4885RECQL 2763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.